Projects per year
Fingerprint
Dive into the research topics where Kris Van Moer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
C2I: CHECKPOINT INHIBITORS IMPROVEMENT FOR THE TREATMENT OF CANCER
Janji, B., Gao, R. & Van Moer, K.
1/04/22 → 31/10/25
Project: Research
-
SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
Hasmim, M., Xiao, M., Van Moer, K., Kumar, A., Oniga, A., Mittelbronn, M., Duhem, C., Chammout, A., Berchem, G., Thiery, J. P., Volpert, M., Hollier, B., Noman, M. Z. & Janji, B., 9 Sept 2022, In: Frontiers in Immunology. 13, 1 p., 982821.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
The β-carboline Harmine improves the therapeutic benefit of anti-PD1 in melanoma by increasing the MHC-I-dependent antigen presentation
Noman, M. Z., Bocci, I. A., Karam, M., Moer, K. V., Bosseler, M., Kumar, A., Berchem, G., Auclair, C. & Janji, B., 15 Nov 2022, In: Frontiers in Immunology. 13, 980704.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Epithelial to mesenchymal transition regulates surface pd-l1 via cmtm6 and cmtm7 induction in breast cancer
Xiao, M., Hasmim, M., Lequeux, A., Van Moer, K., Tan, T. Z., Gilles, C., Hollier, B. G., Thiery, J. P., Berchem, G., Janji, B. & Noman, M. Z., 9 Mar 2021, In: Cancers. 13, 5, p. 1-12 12 p., 1165.Research output: Contribution to journal › Article › Research › peer-review
Open Access14 Citations (Scopus) -
Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy
Lequeux, A., Noman, M. Z., Xiao, M., Van Moer, K., Hasmim, M., Benoit, A., Bosseler, M., Viry, E., Arakelian, T., Berchem, G., Chouaib, S. & Janji, B., 15 Jul 2021, In: Oncogene. 40, 28, p. 4725-4735 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access36 Citations (Scopus) -
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy
Noman, M. Z., Parpal, S., van Moer, K., Xiao, M., Yu, Y., Viklund, J., de Milito, A., Hasmim, M., Andersson, M., Amaravadi, R. K., Martinsson, J., Berchem, G. & Janji, B., Apr 2020, In: Science advances. 6, 18, eaax7881.Research output: Contribution to journal › Article › Research › peer-review
Open Access113 Citations (Scopus)